Bioelectrical impedance analysis of body composition and survival in patients with heart failure
- PMID: 30447075
- PMCID: PMC6436517
- DOI: 10.1002/clc.23118
Bioelectrical impedance analysis of body composition and survival in patients with heart failure
Abstract
Background: Studies have shown that higher body mass index (BMI) is associated with improved prognosis in heart failure (HF), and this is often termed the obesity paradox.
Hypothesis: Analysis of body composition may reveal that muscle mass rather than adipose tissue accounts for the obesity paradox.
Methods: Bioelectrical impedance analysis of body composition in 359 outpatients with HF was performed using an In Body 520 body composition scale (Biospace Inc., California). Body fat and lean mass were indexed by height (m2 ). The cohort was stratified by median fat and lean mass indexed by height.
Results: The mean age of patients studied was 56 ± 14; mean left ventricular ejection fraction was 38 ± 16%. Patients with higher indexed body fat mass had improved 5-year survival over patients with lower indexed body fat mass (90.2% vs 80.1%, P = 0.008). There was also improved survival in patients with high vs low indexed lean body mass (89.3% vs 80.9%, P = 0.036). On multivariable analysis, higher indexed body fat mass, but not lean body mass, was independently associated with improved survival (HR 0.89, per kg/m2 increase in indexed body fat mass, P = 0.044); however, this was attenuated after adjustment for diabetes. The combination of low lean with low-fat mass was independently associated with poor prognosis.
Conclusions: Our data suggest that higher fat mass-and to a lesser extent higher lean mass-is associated with improved outcomes in HF. Further investigations of specific components of body composition and outcomes in HF are warranted.
Keywords: body composition; heart failure; obesity paradox; outcomes.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
Dr Fonarow reports a potential conflict of interest pertaining to research support from the National Institute of Health (significant) and consulting work for Amgen (modest), Janssen (modest), Medtronic (modest), Novartis (significant), and St Jude (modest). Dr Horwich reports a potential conflict of interest pertaining to research support from the National Institute of Health (significant) and Samsung (modest).
Figures



Similar articles
-
Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study.PLoS Med. 2019 Sep 24;16(9):e1002916. doi: 10.1371/journal.pmed.1002916. eCollection 2019 Sep. PLoS Med. 2019. PMID: 31550265 Free PMC article.
-
High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox.BMC Geriatr. 2021 Jan 6;21(1):16. doi: 10.1186/s12877-020-01950-9. BMC Geriatr. 2021. PMID: 33407196 Free PMC article.
-
Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure.Ann Med. 2016 Dec;48(8):603-613. doi: 10.1080/07853890.2016.1197415. Epub 2016 Jul 16. Ann Med. 2016. PMID: 27427379 Review.
-
Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox.Mayo Clin Proc. 2014 Aug;89(8):1072-9. doi: 10.1016/j.mayocp.2014.04.025. Epub 2014 Jul 16. Mayo Clin Proc. 2014. PMID: 25039037
-
Obesity and the obesity paradox in heart failure.Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):409-14. doi: 10.1016/j.pcad.2013.10.004. Epub 2013 Oct 5. Prog Cardiovasc Dis. 2014. PMID: 24438732 Review.
Cited by
-
Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.J Diabetes Res. 2021 May 28;2021:5551216. doi: 10.1155/2021/5551216. eCollection 2021. J Diabetes Res. 2021. PMID: 34136580 Free PMC article.
-
Fat Mass is Associated with Subclinical Left Ventricular Systolic Dysfunction in Patients with Type 2 Diabetes Mellitus Without Established Cardiovascular Diseases.Diabetes Ther. 2023 Jun;14(6):1037-1055. doi: 10.1007/s13300-023-01411-7. Epub 2023 May 4. Diabetes Ther. 2023. PMID: 37140878 Free PMC article.
-
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC.Eur J Heart Fail. 2025 Jul;27(7):1273-1293. doi: 10.1002/ejhf.3676. Epub 2025 May 6. Eur J Heart Fail. 2025. PMID: 40328668 Free PMC article.
-
Association of Fontan Pathophysiology With Plasma Bile Acids.JACC Adv. 2025 Feb;4(2):101563. doi: 10.1016/j.jacadv.2024.101563. Epub 2025 Jan 18. JACC Adv. 2025. PMID: 39827765 Free PMC article.
-
Obesity paradox and heart failure.Eat Weight Disord. 2021 Aug;26(6):1697-1707. doi: 10.1007/s40519-020-00982-9. Epub 2020 Aug 26. Eat Weight Disord. 2021. PMID: 32851592 Review.
References
-
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Heart disease and stroke statistics—2018 update: A report From the American Heart Association. 2018;137(12):e67‐e492. 10.1161/CIR.0000000000000558. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous